Clin2
NCT06187155Possibly a fitRecruiting

How education level affects warfarin self-management

Atrial Fibrillation and FlutterMechanical Mitral Valve Prosthesis

Part of Heart & circulation clinical trials.

This study looks at how a person's education level affects their ability to manage their own blood-thinning medication (like warfarin). It aims to see if more education leads to better health outcomes.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
586 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have been taking a vitamin K antagonist (like warfarin) for at least 6 months.
  • You have not had a life-threatening bleed or dangerous blood clot in the past.
  • You can read and write, or you live with a caregiver who can help you manage your medication.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT03862859Recruiting· Phase 4
Warfarin safety for people with atrial fibrillation on dialysis

This trial studies whether the blood thinner warfarin is safe and effective for preventing stroke and blood clots in people who have atrial fibrillation and need long-term dialysis. It may help your care team better balance clot prevention against bleeding risk.

Herlev, Herlev
NCT06789588Enrolling by invitation· Phase 3
Better warfarin therapy for atrial fibrillation

This study tests a better way to manage warfarin (a blood thinner) for people with atrial fibrillation (an irregular heartbeat). The goal is to improve treatment and help prevent stroke.

Recife, Pernambuco
NCT03636295Recruiting· Phase 3
Testing a lower INR goal to reduce bleeding in mechanical valves

This Phase 3 study tests whether aiming for a lower blood-thinning test result (INR) can reduce bleeding risk in people with a specific type of mechanical heart valve. The trial checks if this lower INR goal is safer while still protecting against dangerous clots.

Genk, Limburg
NCT02741349Recruiting
Checking stroke and bleeding risks in atrial fibrillation

This study looks at how to better predict both stroke risk and bleeding risk in people with atrial fibrillation. It may help doctors choose safer blood-thinner treatment and follow-up plans.

Paris
NCT00162474Recruiting
Study of factors that affect warfarin treatment

This study looks at why some people process warfarin (a blood-thinning medicine) differently. It aims to learn what personal or medication factors may affect how well warfarin works, so future dosing can be safer and more accurate.

Jerusalem
NCT07159399Enrolling by invitation
Pharmacist-led education to help patients take blood thinners

This trial tests if talking with a pharmacist helps people with atrial fibrillation remember to take their blood thinner medicine correctly. It may improve stroke prevention.

Taipei

Hear when a new Atrial Fibrillation and Flutter trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.